Hillmar I et al. |
Effects of a thio analog of platelet-activating factor on platelet aggregation and adenosine 3',5'-monophosphate concentration in hepatocyte suspensions and in platelets. A comparison with the naturally occurring compound. |
1984 |
Hoppe-Seyler's Z. Physiol. Chem. |
pmid:6325321
|
Krishnamurthi S et al. |
Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. |
1984 |
Biochem. Pharmacol. |
pmid:6091666
|
Valone FH |
Isolation of a platelet membrane protein which binds the platelet-activating factor 1-0-hexadecyl-2-acetyl-SN-glycero-3-phosphorylcholine. |
1984 |
Immunology |
pmid:6325330
|
Smith RJ et al. |
Effects of an anion channel blocker, 4, 4'-diisothiocyano-2,2'-disulfonic acid stilbene (DIDS), on human neutrophil function. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6329191
|
Kamitani T et al. |
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. |
1984 |
Eur. J. Pharmacol. |
pmid:6144557
|
Tokumura A et al. |
Contractile effect of 1-O-hexadecyl-2-O-acetyl-sn-glycero-3-phosphocholine on strips of isolated rat intestine. |
1984 |
J. Pharm. Pharmacol. |
pmid:6144763
|
Pirotzky E et al. |
Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys. |
1984 |
Kidney Int. |
pmid:6144811
|
Gómez-Cambronero J et al. |
The role of calcium ions in the process of acetyltransferase activation during the formation of platelet-activating factor (PAF-acether). |
1984 |
Biochem. J. |
pmid:6146309
|
Colditz IG and Movat HZ |
Desensitization of acute inflammatory lesions to chemotaxins and endotoxin. |
1984 |
J. Immunol. |
pmid:6088633
|
Cervoni P et al. |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro. |
1984 |
Br. J. Pharmacol. |
pmid:6091835
|
Fink KL and Gross RW |
Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds. |
1984 |
Circ. Res. |
pmid:6091941
|
Kulikov VI and Bergel'son LD |
[Binding of 1-0-alkyl-2-0-acetyl-sn-glycero-3-phosphocholine (thrombocyte activating factor) by plasma components. Exchange of the thrombocyte activating factor between lipoproteins and thrombocytes]. |
1984 |
Biokhimiia |
pmid:6093897
|
Haye B et al. |
Interactions between thyreostimulin and PAF-acether on thyroid cell metabolism. |
1984 |
Eur. J. Pharmacol. |
pmid:6094205
|
Gordeev KIu et al. |
[A bioregulator of lipid nature--a platelet activating factor (PAF)]. |
1984 |
Bioorg. Khim. |
pmid:6099122
|
Wang ZY |
[Advances in the physiopathology of platelets]. |
1984 |
Zhonghua Nei Ke Za Zhi |
pmid:6099795
|
Clay KL et al. |
Structure elucidation of platelet activating factor derived from human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6430285
|
Nishihira J et al. |
Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid). |
1984 |
J. Biochem. |
pmid:6430883
|
Knauer KA et al. |
Platelet augmentation of IgE-dependent histamine release from human basophils and mast cells. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6200443
|
Kazimierczak W et al. |
Deuterium-oxide-induced histamine release from basophils of allergic subjects. I. Responsiveness to deuterium oxide requires an activation step. |
1984 |
Am. Rev. Respir. Dis. |
pmid:6201094
|
Feuerstein G et al. |
Hypotension produced by platelet-activating factor is reversed by thyrotropin-releasing hormone. |
1984 |
Circ. Shock |
pmid:6432359
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
O'Flaherty JT et al. |
Diacylglycerols enhance human neutrophil degranulation responses: relevancy to a multiple mediator hypothesis of cell function. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6433920
|
Mendlovic F et al. |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6435614
|
Malpass TW et al. |
The effect of prostacyclin infusion on platelet hemostatic function in patients undergoing cardiopulmonary bypass. |
1984 |
J. Thorac. Cardiovasc. Surg. |
pmid:6231433
|
Willoughby WF and Willoughby JB |
Immunologic mechanisms of parenchymal lung injury. |
1984 |
Environ. Health Perspect. |
pmid:6234162
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Sänze JU et al. |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse. |
1984 |
Biomed. Biochim. Acta |
pmid:6440544
|
Sills RH |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations. |
1984 |
Am J Pediatr Hematol Oncol |
pmid:6442830
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kulikov VI et al. |
[Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. |
1984 |
Biokhimiia |
pmid:6542803
|
Kenzora JL et al. |
Effects of acetyl glyceryl ether of phosphorylcholine (platelet activating factor) on ventricular preload, afterload, and contractility in dogs. |
1984 |
J. Clin. Invest. |
pmid:6480824
|
Jackson EM et al. |
High performance liquid chromatography of platelet-activating factors. |
1984 |
J. Lipid Res. |
pmid:6481248
|
Dewar A et al. |
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. |
1984 |
J. Pathol. |
pmid:6481526
|
Goldstein BM et al. |
Effect of platelet activating factor (PAF) on blood flow distribution in the spontaneously hypertensive rat. |
1984 |
Life Sci. |
pmid:6482659
|
Baldo BA and Tovey ER |
Allergy, allergens and allergen standardization. |
1984 |
Med. J. Aust. |
pmid:6482786
|
Saeki S et al. |
Effect of 1-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine on blood pressure by intra-lateral ventricular injection in the rat. |
1984 |
Med J Osaka Univ |
pmid:6482814
|
Nishizawa EE and Della-Coletta AA |
The formation of a thrombin-like material (TLM) following stimulation of leukocytes. |
1984 |
Thromb. Res. |
pmid:6484896
|
Buxton DB et al. |
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. |
1984 |
J. Biol. Chem. |
pmid:6693418
|
Satouchi K et al. |
Metabolism of 1-O-alkyl-2-acetyl-sn-glycerol by washed rabbit platelets: formation of platelet activating factor. |
1984 |
Arch. Biochem. Biophys. |
pmid:6486825
|
Nakamura N et al. |
Synthesis and biological activities of bioisosteric O-carba-analogues of platelet activating factor (PAF). |
1984 |
Chem. Pharm. Bull. |
pmid:6488414
|
Sakamoto H et al. |
Stimulation of leukocyte phagocytic activity by the platelet release reaction. |
1984 |
Pathology |
pmid:6462776
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Chilton FH et al. |
1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. |
1984 |
J. Biol. Chem. |
pmid:6434535
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Colditz IG and Movat HZ |
Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. |
1984 |
J. Immunol. |
pmid:6470487
|
Patterson R et al. |
Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys. |
1984 |
J. Lab. Clin. Med. |
pmid:6470563
|
Caramelo C et al. |
Presence of platelet-activating factor in blood from humans and experimental animals. Its absence in anephric individuals. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6732788
|
Lenihan DJ and Lee TC |
Regulation of platelet activating factor synthesis: modulation of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase by phosphorylation and dephosphorylation in rat spleen microsomes. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6732789
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular Ca2+. |
1984 |
Arch. Biochem. Biophys. |
pmid:6430234
|
Kasuya Y et al. |
Hypotensive actions of some analogues of platelet-activating factor (PAF) with higher potencies than natural PAF. |
1984 |
Can. J. Physiol. Pharmacol. |
pmid:6733593
|
Page CP et al. |
Platelets and bronchospasm. |
1984 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6735490
|
Jouvin-Marche E et al. |
Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes. |
1984 |
J. Immunol. |
pmid:6736649
|
Ostermann G et al. |
Cooperative effects of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) and exogenous arachidonic acid in stimulation of human blood platelets. |
1984 |
Thromb. Res. |
pmid:6710440
|
Levi R et al. |
Acetyl glyceryl ether phosphorylcholine (AGEPC). A putative mediator of cardiac anaphylaxis in the guinea pig. |
1984 |
Circ. Res. |
pmid:6692502
|
Humphrey DM et al. |
Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. |
1984 |
Lab. Invest. |
pmid:6694349
|
Masugi F et al. |
Effect of 1-alkyl-2-acetyl-sn-glycero-3-phosphorylcholine inhibitor on the reduction of one-kidney, one clip hypertension after unclipping in the rat. |
1984 |
Life Sci. |
pmid:6694519
|
Bottecchia D et al. |
Influence of the pure synthetic PAF (platelet aggregating factor) on clot retraction and platelet aggregation. |
1984 |
Scand J Haematol |
pmid:6695148
|
Blank ML et al. |
A new class of antihypertensive neutral lipid: 1-alkyl-2-acetyl-sn-glycerols, a precursor of platelet activating factor. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6696762
|
Williams KA and Haslam RJ |
Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor). |
1984 |
Biochim. Biophys. Acta |
pmid:6696908
|
Albert DH and Snyder F |
Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages. |
1984 |
Biochim. Biophys. Acta |
pmid:6435681
|
Hoffman DR et al. |
Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts. |
1984 |
Blood |
pmid:6696992
|
Basran GS et al. |
Platelet-activating factor: a possible mediator of the dual response to allergen? |
1984 |
Clin. Allergy |
pmid:6697475
|
Kelton JG et al. |
Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. |
1984 |
J. Lab. Clin. Med. |
pmid:6699475
|
Feuerstein G et al. |
Effect of platelet-activating factor on coronary circulation of the domestic pig. |
1984 |
Am. J. Physiol. |
pmid:6703081
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Kumar R et al. |
A facile route to semi-synthesis of acetyl glycerylether phosphoethanolamine and its choline analogue. |
1984 |
J. Lipid Res. |
pmid:6707528
|
Denburg JA et al. |
Platelet activating factor: regulation by mast cells and aspirin. |
1984 |
Agents Actions |
pmid:6711391
|
El Tamer A et al. |
Studies on ether phospholipids. I. A new method of determination using phospholipase A1 from guinea pig pancreas: application to Krebs II ascites cells. |
1984 |
Biochim. Biophys. Acta |
pmid:6712966
|
Touqui L et al. |
Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets. |
1984 |
Experientia |
pmid:6714369
|
Masugi F et al. |
[Etiological studies of hypertension. G. APRL (antihypertensive polar renomedullary lipid)]. |
1984 |
Nippon Rinsho |
pmid:6716685
|
Kester M et al. |
The potentiation of arterial contraction with platelet activating factor. |
1984 |
Pflugers Arch. |
pmid:6718228
|
Pelczar-Wissner CJ et al. |
Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect. |
1984 |
Am. J. Hematol. |
pmid:6720685
|
Guay DR and Richard A |
Heparin-induced thrombocytopenia--association with a platelet aggregating factor and cross-sensitivity to bovine and porcine heparin. |
1984 |
Drug Intell Clin Pharm |
pmid:6723517
|
Poitevin B et al. |
Paf-acether generates chemiluminescence in human neutrophils in the absence of cytochalasin B. |
1984 |
Immunopharmacology |
pmid:6724877
|
Kawaguchi H and Yasuda H |
Platelet-activating factor stimulates phospholipase in quiescent Swiss mouse 3T3 fibroblast. |
1984 |
FEBS Lett. |
pmid:6436057
|
Kasuya Y et al. |
Possible role of endothelium in the vasodilator response of rat thoracic aorta to platelet activating factor (PAF). |
1984 |
J. Pharmacobio-dyn. |
pmid:6726619
|
Kramer RM et al. |
Metabolism of platelet-activating factor in human platelets. Transacylase-mediated synthesis of 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. |
1984 |
J. Biol. Chem. |
pmid:6436245
|
McGivern DV and Basran GS |
Synergism between platelet-activating factor (PAF-acether) and prostaglandin E2 in man. |
1984 |
Eur. J. Pharmacol. |
pmid:6592097
|
Beaubien BB et al. |
Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6594998
|
Roubin R et al. |
The role of immunomodulators in the production of lipid mediators by macrophages (M phi). |
1984 |
Int J Tissue React |
pmid:6596298
|
Archer CB et al. |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. |
1984 |
Br. J. Dermatol. |
pmid:6581831
|
Andreesen R et al. |
Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine. |
1984 |
J. Natl. Cancer Inst. |
pmid:6582303
|
Prescott SM et al. |
Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. |
1984 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:6587368
|
Iñarrea P et al. |
Characteristics of the binding of platelet-activating factor to platelets of different animal species. |
1984 |
Eur. J. Pharmacol. |
pmid:6510472
|
Kornecki E et al. |
Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines. |
1984 |
Science |
pmid:6150550
|
Chignard M et al. |
Paf-acether formation and arachidonic acid freeing from platelet ether-linked glyceryl-phosphorylcholine. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6437404
|
Schleimer RP et al. |
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. |
1984 |
J. Allergy Clin. Immunol. |
pmid:6208229
|
Archer CB et al. |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. |
1984 |
Prostaglandins |
pmid:6203139
|
Bussolino F et al. |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. |
1984 |
Exp. Hematol. |
pmid:6333353
|
Nishihira J et al. |
Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid during labor. |
1984 |
Lipids |
pmid:6527609
|
Gunby P |
A new piece for the puzzle of inflammation. |
1984 |
JAMA |
pmid:6420583
|
Lian EC et al. |
Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma. |
1984 |
Thromb. Res. |
pmid:6420930
|
Billah MM and Siegel MI |
Calmodulin antagonists inhibit formation of platelet-activating factor in stimulated human neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422930
|
Prevost MC et al. |
Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6422938
|